|
For the year ended 31 December 2016 |
| Capital expenditures (note 11,12,13) |
24,608 |
78,458 |
16,240 |
31,250 |
150,556 |
| Impairment of property, plant and equipment (note 11) |
-5,162 |
- |
- |
- |
-5,162 |
| Impairment of intangible assets-excluding goodwill (note 13) |
-376 |
- |
- |
- |
-376 |
| Impairment of Goodwill (note 13) |
-2,510 |
- |
-2,766 |
- |
-5,276 |
| (Reversal of allowance)/allowance for doubtful debtors (note 20) |
-917 |
-433 |
487 |
276 |
-587 |
| Investment in associates & joint ventures (note 15) |
742 |
4,3217 |
3,551 |
- |
8,614 |
| Non-qualified deferred compensation plans (note 17, 25) |
- |
4,364 |
- |
- |
4,364 |
Capital expenditures consist of additions of property, plant and equipment, intangible assets and investment properties.
Impairment charges are included in the income statement.
Information by business activities
|
For the year ended 31 December 2016 |
| Turnover |
907,451 |
592,880 |
8,822 |
1,509,153 |
Reconciliation of profit
Finance income and costs, and fair value gains and losses on financial assets are not allocated to individual segments as the underlying instruments are managed on a Group basis.
|
Group |
| Profit before interest and taxes |
157,012
|
151,492
|
| Income from participations and investments |
162 |
1,926 |
| Finance income |
899 |
2,900 |
| Finance expense |
-65,033 |
-67,303 |
| Losses from foreign exchange differences |
-22,326 |
-25,982 |
| Share of profit of associates (note 15) |
1,540 |
1,577 |
| Share of loss of joint ventures (note 15) |
-9,028 |
-1,085 |
| Profit before taxes |
63,226 |
63,525 |